1 completed, 1 not yet recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
Follow Xingwang Zhu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combined Oscillation-Volume guarantEe Study HFOV, HFOV+VG - Respiratory Distress Syndrome (& [Hyaline Membrane Disease]), Bronchopulmonary Dysplasia (BPD) | Not applicable | Not yet recruiting | Xingwang Zhu | 348 | 2026-02-01 | 2026-01-30 |
| NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS) noninvasive high-frequency ventilation (nHFOV), nasal continuous positive airway pressure (nCPAP) - Preterm Infants | Not applicable | Completed | Xingwang Zhu | 340 | 2017-04-27 | 2021-03-02 |
Bronchopulmonary Dysplasia (1) · Hyaline Membrane Disease (1) · Respiratory Distress Syndrome (1)
Continuous Positive Airway Pressure (1)
China (1)
Shi Yuan, PhD (1)